Home Elixir Medical

Elixir Medical

Elixir Medical Corporation Announces Outstanding 5-Year Clinical Data for CE Mark-approved DESolve® Novolimus Eluting Bioresorbable Coronary Scaffold System

The company reports:  Excellent Six-Month Safety and Efficacy Results for Next-Generation Thin-strut DESolve® Cx Novolimus Eluting Bioresorbable...

Elixir Medical to Release Five-year DESolve Nx Trial Data, Showcase Next-Generation Coronary and SFA Bioresorbable Scaffold Systems at EuroPCR 2017

Long-term 5-year clinical follow-up data for the DESolve® Novolimus eluting coronary scaffold system, 6-month clinical and imaging...